Table 1 Key characteristics of the selected studies.
Author | Journal | Year | Country | N | Outcome(s) |
|---|---|---|---|---|---|
Brea et al.15 | Clin Chem Lab Med | 2009 | Spain | 224 | Functional outcome |
Ghosh et al.11 | Neuroimmunol and Neuroinflammation | 2018 | India | 30 | Stroke severity and Functional outcome |
Jauch et al.16 | Stroke | 2006 | USA | 208 | Stroke severity, Infarcted brain volume, and Functional outcome |
Kurakina et al.9 | Sovrem Tekhnologii Med | 2021 | Russia | 50 | Stroke severity, Infarcted brain volume, Functional outcome, and Death rates |
Oh et al.17 | Arch Neurolog | 2003 | South Korea | 81 | Stroke severity and Infarcted brain volume |
Oh et al.18 | Yonsei Med J | 2002 | South Korea | 109 | Stroke severity and Functional outcome |
Park et al.19 | Critical Care | 2013 | South Korea | 175 | Functional outcome |
Purroy et al.10 | Acta Neurol Scand | 2021 | Spain | 332 | Infarcted brain volume |
Shash et al.12 | The Egyptian J of Neurol, Psychiatry and Neurosurg | 2021 | Egypt | 37 | Stroke severity and Death rates |
Singh et al.20 | Clinica Chimica Acta | 2013 | India | 100 | Stroke severity |
Wunderlich et al.21 | Stroke | 1999 | Germany | 52 | Infarcted brain volume |
